Extreme-risk category: High prevalence among stable coronary patients and an emerging widening treatment gap in achieving LDL-cholesterol less than 55 mg/dL

Rallidis, LS; Kiouri, E; Katsimardos, A; Kotakos, C

Rallidis, LS (reprint author), 74 Thermopylon St, Argyroupolis 16451, Greece.

ATHEROSCLEROSIS, 2018; 275 (): 262

Abstract

Background and aims: The latest guidelines from the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology......

Full Text Link